Exact Sciences

Historical price data

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of cancer through innovative screening technologies. The company's flagship product, Cologuard, revolutionized colorectal cancer screening by providing a convenient at-home alternative to traditional colonoscopy. Through strategic acquisitions and internal development, Exact Sciences has built a comprehensive cancer diagnostics portfolio spanning screening, early detection, and personalized treatment guidance across multiple cancer types.

Molecular diagnostics platform combining stool-based DNA testing, liquid biopsy technologies, and genomic analysis for cancer screening, early detection, and treatment guidance across multiple cancer types.

Competes with traditional screening methods like colonoscopy, emerging blood-based screening tests from Guardant Health and Grail, and established genomic testing companies like Myriad Genetics and Foundation Medicine. Differentiated by established commercial infrastructure, payer relationships, and comprehensive approach to cancer care from screening through treatment guidance.